---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037589"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:45:47.831913+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience receives Nasdaq bid-price deficiency notice; restates lease accounting for 2021–2024 periods

## Summary
- Nasdaq notified INVO on Sep 18, 2024, that bid price was below $1 for 34 consecutive days; 180-day cure to May 17, 2025.
- If not compliant by May 17, 2025, a second 180-day period may be granted if other initial listing standards are met.
- Company considering reverse stock split among options to regain compliance.
- Audit committee concluded financial statements from Jun 2021–Jun 2024 should no longer be relied upon due to incorrect discount rate used for operating lease ROU assets/liabilities.
- Restatement does not affect revenue, results, EPS, or net equity; no change to operations or compensation.

## SEC filing metadata
- accession: 0001493152-24-037589
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 4.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224037589/0001493152-24-037589-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224037589/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037589
- JSON: https://secwatch.observer/filing/0001493152-24-037589.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037589.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
